Shuttle Pharmaceuticals Holdings (SHPH) Convertible Debt (2023 - 2025)

Shuttle Pharmaceuticals Holdings' Convertible Debt history runs 3 years deep, the most recent figure standing at $10.0 million for Q2 2025.

• On a quarterly basis, Convertible Debt changed 0.0% year-over-year to $10.0 million in Q2 2025; TTM through Jun 2025 was $10.0 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $10.0 million, up 7302.53% from the prior year.
• Convertible Debt steadied at $10.0 million in Q2 2025 per SHPH's latest filing, from $10.0 million in the prior quarter.
• Across five years, Convertible Debt topped out at $10.0 million in Q2 2024 and bottomed at $122309.0 in Q2 2023.
• The 3-year median for Convertible Debt is $10.0 million (2024), against an average of $6.3 million.
• Across the five-year window, Convertible Debt jumped 8076.01% in 2024 and changed 0.0% in 2025, its largest moves.
• Year by year, Convertible Debt stood at $135089.0 in 2023, then surged by 7302.53% to $10.0 million in 2024, then changed by 0.0% to $10.0 million in 2025.
• Per Business Quant, the three latest SHPH Convertible Debt figures stand at $10.0 million (Q2 2025), $10.0 million (Q1 2025), and $10.0 million (Q4 2024).